Plewman Patrick 4

What Happened Patrick Plewman, Senior VP for Diagnostic Services at Quest Diagnostics (DGX), was granted restricted stock units (RSUs) totaling 10,961 shares (1,952 + 9,009) on Feb 18, 2026. To cover tax withholding on vesting, 244 shares were surrendered at $210.01 (≈ $51,242) and 293 shares at $206.99 (≈ $60,648) on Feb 18. Separately, on Feb 19 he sold 958 shares in an open-market sale at $204.83 for approximately $196,227. These transactions resulted in gross proceeds of about $196.2K from the open-market sale and roughly $111.9K in shares surrendered for taxes.

Key Details

• Transaction dates and amounts:
  • 2026-02-18: Award of 1,952 RSUs (no purchase price).
  • 2026-02-18: 244 shares surrendered for tax withholding at $210.01 (≈ $51,242).
  • 2026-02-18: 293 shares surrendered for tax withholding at $206.99 (≈ $60,648).
  • 2026-02-19: Open-market sale of 958 shares at $204.83 (≈ $196,227).
  • 2026-02-18: Additional award/derivative of 9,009 RSUs (no purchase price).
• Shares owned after the transactions: Not disclosed in the filing.
• Footnotes:
  • F1: The awards are restricted stock units (RSUs).
  • F2: The 244 and 293-share dispositions were to the issuer solely to cover tax withholding on RSU vesting.
  • F3: The reported sale was effected pursuant to a Rule 10b5-1 sales plan (pre-arranged plan).
  • F4: Notes an options vesting schedule (vests in three equal annual installments); no option exercise was reported in these transactions.
• Filing timeliness: Reported on 2026-02-20 for transactions on 2026-02-18 and 02-19 — filing appears to be timely (no late filing indicated).

Context

• RSU grants are compensation that vests and are taxable; surrendering shares to cover withholding is common and routine, and not necessarily a signal about the insider’s view of the company.
• The open-market sale being executed under a 10b5-1 plan indicates it was part of a pre-established trading arrangement rather than a spontaneous trade.
• Purchases (bullish bets) are generally more informative than routine withholding or planned sales; here the primary items are awards (compensation) plus routine tax withholding and a planned sale.